Michael E. Brandt

Michael has advised on the following significant matters:

• Galata Acquisition Corp., a special purpose acquisition company led by Callaway Capital, in its business combination with Marti Technologies Inc., Turkey’s leading mobility app.
• Varroc Engineering Ltd. in its €600 million sale of Varroc Lighting Systems to Plastic Omnium.
• HBC in its investment in Convene and creation of a leading flex space operator.
• DigitalBridge Group in the $3.2 billion sale of its Wellness Infrastructure business to Highgate Capital Investments and Aurora Health Network.
• AdaptHealth Corp. in its $2 billion acquisition of home medical equipment provider AeroCare.
• AdaptHealth LLC in its $142 million common stock public offering, and its $600, $500 million and $350 million senior notes offerings.
• AdaptHealth Corp., a leading home medical equipment and supplies company, in equity investments from One Equity Partners and Deerfield Management in connection with AdaptHealth’s acquisitions of Solara Medical Supplies, LLC and ActivStyle, Inc.
• Seaport Capital in its strategic investment in Linen King, a regional leader in healthcare laundry services.
• The Hudson’s Bay Company Shareholder Group in its $1.4 billion agreement with HBC to take the company private.
• Hudson’s Bay Company in its $100 million sale of the Lord + Taylor brand and related intellectual property to Le Tote.
  
• Home medical equipment company AdaptHealth in its business combination with special purpose acquisition company DFB Healthcare Acquisitions Corp.
  
• Seaport Capital in its strategic investment in data collection provider All Traffic Data.
• HBC in its agreement with SIGNA Retail Holdings to combine HBC Europe with Germany’s Karstadt Warenhaus GmbH, creating Germany’s leading retailer with annual revenue in excess of €5 billion, and the sale to SIGNA of 50% of HBC’s German real estate assets to form a 50-50 real estate joint venture with SIGNA valued at €3.25 billion.
• Keg Logistics LLC on its acquisition of Keg Credit, LLC, which combines two of the leading keg providers in the U.S. craft brewing industry.
• Hudson’s Bay Company in a $500 million equity investment by Rhône Capital in the form of 8-year mandatory convertible preferred shares. (named "Private Equity Deal of the Year" at the 2018 IFLR Americas Awards).
• Twin Haven Capital Partners, LLC, one of the largest stockholders of Hawaiian Telcom, in connection with the approximately $650 million pending merger of Hawaiian Telcom and Cincinnati Bell Inc.
• Aeolus, its founder and management team in the acquisition of a controlling interest in Aeolus by Elliott Management.
• Aralez Pharmaceuticals in its acquisition of the U.S. rights to beta-blocker Toprol-XL® from AstraZeneca.
• Generation Investment Management, a Seventh Generation shareholder, in connection with Seventh Generation’s acquisition by Unilever.
• Colony Capital, Inc. in its $17 billion merger of equals with NorthStar Asset Management Group Inc. and NorthStar Realty Finance Corp. to create Colony NorthStar, Inc., with $58 billion of assets under management.
• Hudson’s Bay Company in its $250 million acquisition of Gilt.
• NAC Holdings LLC, a Seaport Capital portfolio company and owner of Net Access, in the sale of Net Access to Cologix.
• Hudson’s Bay Company in the formation of HBS Global Properties, a joint venture with Simon Property Group valued at $1.8 billion, and in its subsequent sales of $533 million and $50 million of its equity in HBS.
• Clovis Oncology in its $316.2 million stock offering.
• Hudson’s Bay Company in its €2.82 billion, cross-border acquisition of Galeria Kaufhof.
• New York Life in its acquisition of a majority of John Hancock’s participating whole life insurance block, as well as the sale of its retirement plan services business to Hancock.
• Worley Claims Services and its owners, including Seaport Capital, in the sale of a majority stake in Worley to Aquiline Capital Partners.
• Clovis Oncology in its $287.5 million bond offering.
• Dolce Vita Holdings, Inc. in its acquisition by Steve Madden.
• Clovis Oncology in its acquisition of EOS (Ethical Oncology Science), a privately held Italian biopharmaceutical company, for up to $420 million.
• Seven Mile Capital Partners in its acquisition of Microporous Products from Polypore International Inc. for $120 million.
• Constitution Medical Investors, Inc. in its sale to Roche Diagnostics.
• Varroc Group in its acquisition of Visteon Corp.’s automotive lighting business.
• Morgan Stanley in its sale of its mortgage servicing business, Saxon, to Ocwen Financial Corporation for a base purchase price plus approximately $1.2 billion for servicing advance receivables outstanding.
• Warburg Pincus in connection with its investments in Benchmark Solutions, Constitution Medical Investors, Hana Biosciences Inc., Home Dialysis Plus, RegionalCare Hospital Partners and other companies.
• Fiat in its acquisition of the equity interests in Chrysler of The United States Department of the Treasury and the Canadian government.
• Fiat in its acquisitions from Chrysler of additional equity interests in Chrysler, raising Fiat’s percentage ownership of Chrysler above 50%.
• Agusta SpA in its buyout of Bell Helicopter Textron from a joint venture to build a civilian tiltrotor helicopter.
• Brookfield Asset Management Inc. in its $2.625 billion cornerstone investment in General Growth Properties and its subsequent $1.7 billion acquisition of an additional ownership interest in GGP.
• Stiefel Laboratories, Inc. in connection with its acquisitions of Connetics Corporation and Barrier Therapeutics and its $3.6 billion sale to GlaxoSmithKline plc.
• Pharmion Corporation in its sale to Celgene Corp. for $2.9 billion in cash and stock.
• Sbarro, Inc. in its acquisition by MidOcean.